Historical record - last NADAC effective date: 1/19/2022
Product Information
OLOPATADINE HCL 0.1% EYE DROPS is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $3.0649 per ML under NDC 62332050105. Its NADAC has been published 135 times since Jul 10, 2019.
FDA first approved this application on Dec 7, 2018.
Strength
1 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332050105
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
1/19/2022
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209919FDA Approved
12/7/2018
On Market Since
12/7/2018
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.1% EYE DROPS has been published 135 times since Jul 10, 2019, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0649 per ML |
|---|---|
| All-time high | $3.4942 (Aug 12, 2020) |
| All-time low | $2.1481 (Jun 23, 2021) |
| Median price | $2.6491 |
| Average price | $2.7121 |
| Largest weekly change | +15.7% (Jan 19, 2022) |
| Weeks tracked | 135 |
| Tracking since | Jul 10, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+41.6%
All
-5.1%
Last surveyed Feb 2, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
olopatadine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROPS, manufactured by Alembic Pharmaceuticals Inc., is $3.0649 per ML (NDC 62332050105), effective Feb 2, 2022.
How has the price of OLOPATADINE HCL 0.1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROPS has declined 5.1%. It has been tracked across 135 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROPS?
Since Jul 10, 2019, the NADAC for OLOPATADINE HCL 0.1% EYE DROPS has ranged from a low of $2.1481 (Jun 23, 2021) to a high of $3.4942 (Aug 12, 2020), with a median of $2.6491 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.1% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLOPATADINE HCL 0.1% EYE DROPS?
OLOPATADINE HCL 0.1% EYE DROPS (NDC 62332050105) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.